Main navigation About Tolmar Science & Innovation Treatments Responsibility Careers News Contact History A legacy of leading-edge product development and partnerships Tolmar is proud to have earned a reputation for performance and innovation. Through a progressive company culture, Tolmar has established a legacy as a trusted name in the research, development and manufacturing of high quality topical products used in dermatology, and extended release dosing forms for products commonly used in urology and oncology. Founded in 2006, we have built a company known internationally for our advanced drug delivery capabilities and our unmatched commitment to our partners, and to the patients and provider communities we serve. Since our inception, Tolmar has produced 22 marketed products supported by 5 New Drug Applications (NDAs) and 17 Abbreviated New Drug Applications (ANDAs) across urology and oncology and dermatology. With more products forthcoming, our dedicated pipeline reflects Tolmar’s future-focused approach. Tolmar Pharmacueticals, Inc. Footer menu Contact Drug Distribution Accreditation – Learn More Media Privacy Policy Site Map Terms & Conditions ©2018-2020 Tolmar Pharmaceuticals, Inc. All rights reserved. TOLMAR, ELIGARD, FENSOLVI and ATRIGEL are trademarks of the TOLMAR group. Third party trademarks, product names, and copyrights belong to their respective owners. Back to Top

Main navigation About Tolmar Science & Innovation Treatments Responsibility Careers News Contact Responsibility Our responsibility stems from our mission to deliver innovative therapies and inventive solutions to advance patient care. At Tolmar, we work with healthcare practitioners and our partners around the world to deliver our products safely, responsibly and consistently to patients. This commitment is reflected in our dedicated engagement with the urology, oncology and hospital communities, and patient advocacy groups. We are dedicated to the communities in which we work and live. Tolmar is proud to be a Made in Colorado program participant, as Colorado is home to our global research and manufacturing facilities. Tolmar is dedicated to optimizing patient access to ELIGARD® (leuprolide acetate for injectable suspension) through our comprehensive benefit verification services and Patient Assistance Program (PAP). Our responsibility to patients includes a commitment to providing high quality educational materials to aid in their understanding and navigation of their diagnosis and treatments. Tolmar Pharmacueticals, Inc. Footer menu Contact Drug Distribution Accreditation – Learn More Media Privacy Policy Site Map Terms & Conditions ©2018-2020 Tolmar Pharmaceuticals, Inc. All rights reserved. TOLMAR, ELIGARD, FENSOLVI and ATRIGEL are trademarks of the TOLMAR group. Third party trademarks, product names, and copyrights belong to their respective owners. Back to Top